The further addition of GCGR agonism in retatrutide introduces Gs-cAMP signalling in hepatocytes, brown adipose tissue, and the central nervous system cell types with limited or no GLP-1R or GIPR expression expanding the tissue scope of the compound's action profile
Glp-1 Receptor Agonist Market Size & Outlook, n.d.) The American Academy of Pediatrics has shifted their position from watchful waiting to aggressive intervention to combat the childhood obesity epidemic, now recommending intervention therapy along with drugs like Ozempic for children 12 and older.[9] This shift in recommendation in late 2024 opens an entire new demographic for targeting the weight loss drug
Joint pain and tissue recovery: BPC-157 and TB-500 target musculoskeletal repair through complementary mechanisms
To test this, we performed in vitro and ex vivo studies in mouse and human islets
(Jalleh and colleagues, review, Journal of Clinical Investigation , 2026.) Sudden vision loss (a condition called NAION) is the scary headline